These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32347624)

  • 21. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.
    Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y
    Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.
    Zimmerman AW; Singh K; Connors SL; Liu H; Panjwani AA; Lee LC; Diggins E; Foley A; Melnyk S; Singh IN; James SJ; Frye RE; Fahey JW
    Mol Autism; 2021 May; 12(1):38. PubMed ID: 34034808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
    Ghanizadeh A; Ayoobzadehshirazi A
    Pediatr Neurol; 2015 Jan; 52(1):77-81. PubMed ID: 25451017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial.
    Ebrahimi P; Seyedmirzaei H; Moradi K; Bagheri S; Moeini M; Mohammadi MR; Akhondzadeh S
    Int Clin Psychopharmacol; 2023 Mar; 38(2):89-95. PubMed ID: 36165508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder.
    Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Jones B; von Hurst PR
    J Steroid Biochem Mol Biol; 2019 Mar; 187():9-16. PubMed ID: 30744880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial.
    Ou J; Smith RC; Tobe RH; Lin J; Arriaza J; Fahey JW; Liu R; Zeng Y; Liu Y; Huang L; Shen Y; Li Y; Cheng D; Cornblatt B; Davis JM; Zhao J; Wu R; Jin H
    J Autism Dev Disord; 2024 Feb; 54(2):628-641. PubMed ID: 36427174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone in combination with other drugs: Experimental research in individuals with autism spectrum disorder.
    Li A; MacNeill B; Curiel H; Poling A
    Exp Clin Psychopharmacol; 2017 Oct; 25(5):434-439. PubMed ID: 29048191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Adding l -Carnitine to Risperidone on Behavioral, Cognitive, Social, and Physical Symptoms in Children and Adolescents With Autism: A Randomized Double-Blinded Placebo-Controlled Clinical Trial.
    Shakibaei F; Jelvani D
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):55-59. PubMed ID: 36735565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.
    Dominick K; Wink LK; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lurasidone for the treatment of irritability and anger in autism spectrum disorders.
    McClellan L; Dominick KC; Pedapati EV; Wink LK; Erickson CA
    Expert Opin Investig Drugs; 2017 Aug; 26(8):985-989. PubMed ID: 28685626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
    DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
    Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Ghaleiha A; Asadabadi M; Mohammadi MR; Shahei M; Tabrizi M; Hajiaghaee R; Hassanzadeh E; Akhondzadeh S
    Int J Neuropsychopharmacol; 2013 May; 16(4):783-9. PubMed ID: 22999292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
    Fung LK; Mahajan R; Nozzolillo A; Bernal P; Krasner A; Jo B; Coury D; Whitaker A; Veenstra-Vanderweele J; Hardan AY
    Pediatrics; 2016 Feb; 137 Suppl 2():S124-35. PubMed ID: 26908468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.
    Tobiasova Z; van der Lingen KH; Scahill L; Leckman JF; Zhang Y; Chae W; McCracken JT; McDougle CJ; Vitiello B; Tierney E; Aman MG; Arnold LE; Katsovich L; Hoekstra PJ; Volkmar F; Bothwell AL; Kawikova I
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):555-64. PubMed ID: 22070180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
    Ghaleiha A; Ghyasvand M; Mohammadi MR; Farokhnia M; Yadegari N; Tabrizi M; Hajiaghaee R; Yekehtaz H; Akhondzadeh S
    J Psychopharmacol; 2014 Jul; 28(7):677-85. PubMed ID: 24132248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone in children with autism and serious behavioral problems.
    McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
    N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.